Phil Schwab
Impact in
- Family Practice top 5%
- Medication Adherence and Compliance
- Geriatrics and Gerontology top 10%
- Pharmaceutical Practices and Patient Outcomes
Papers in
-
- Diabetes Treatment and Management 7
- Diabetes Management and Research 4
- Co-authors
- Andrew Renda (3 shared papers)Chad Moretz (3 shared papers)Shuchita Kaila (2 shared papers)Sari Hopson (2 shared papers)Srinivas Annavarapu (2 shared papers)Amol D. Dhamane (2 shared papers)Benjamin Hall (1 shared paper)Shengsheng Yu (1 shared paper)
- Journals
- Journal of Managed Care & Specialty Pharmacy (7 papers)Diabetes (2 papers)International Journal of COPD (2 papers)Drugs & Aging (2 papers)Molecular Cancer Therapeutics (1 paper)
- Partner nations
- United StatesBelgium
In The Last Decade
Phil Schwab
19 papers receiving 229 citations
Peers
Comparison fields: 5 of 64
- Family Practice 50
- Geriatrics and Gerontology 39
- Endocrinology, Diabetes and Metabolism 63
- Pulmonary and Respiratory Medicine 71
- Issues, ethics and legal aspects 2
Countries citing papers authored by Phil Schwab
This map shows the geographic impact of Phil Schwab's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Phil Schwab with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Phil Schwab more than expected).
Fields of papers citing papers by Phil Schwab
This network shows the impact of papers produced by Phil Schwab. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Phil Schwab. The network helps show where Phil Schwab may publish in the future.
Co-authors
The 25 scholars most cited alongside Phil Schwab, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 21 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2017 | 46 | |
| 2 | 2019 | 34 | |
| 3 | 2016 | 30 | |
| 4 | 2024 | 18 | |
| 5 | 2016 | 18 | |
| 6 | 2021 | 17 | |
| 7 | 2016 | 15 | |
| 8 | 2019 | 11 | |
| 9 | 2017 | 11 | |
| 10 | 2008 | 10 | |
| 11 | 2018 | 9 | |
| 12 | 2016 | 5 | |
| 13 | 2018 | 4 | |
| 14 | 2014 | 3 | |
| 15 | 2020 | 3 | |
| 16 | Is response-guided therapy being applied in the clinical setting? The hepatitis C example. | 2015 | 2 |
| 17 | 2023 | 1 | |
| 18 | 2015 | 1 | |
| 19 | 2020 | 1 | |
| 20 | 2023 | 0 |
About Phil Schwab
Phil Schwab is a scholar working on Endocrinology, Diabetes and Metabolism, Epidemiology, Family Practice, Geriatrics and Gerontology and Surgery, having authored 21 papers that have together received 239 indexed citations. Recurring topics across this work include Diabetes Treatment and Management (7 papers), Pharmaceutical Practices and Patient Outcomes (4 papers), Diabetes Management and Research (4 papers), Medication Adherence and Compliance (4 papers), Pancreatic function and diabetes (2 papers), Heart Failure Treatment and Management (2 papers), Autoimmune and Inflammatory Disorders Research (2 papers) and Rheumatoid Arthritis Research and Therapies (2 papers). The work is most often cited by research in Family Practice (50 citations), Geriatrics and Gerontology (39 citations), Endocrinology, Diabetes and Metabolism (63 citations), Pulmonary and Respiratory Medicine (71 citations) and Issues, ethics and legal aspects (2 citations). Phil Schwab has collaborated with scholars based in United States and Belgium. Frequent co-authors include Andrew Renda, Chad Moretz, Shuchita Kaila, Sari Hopson, Srinivas Annavarapu, Amol D. Dhamane, Benjamin Hall, Shengsheng Yu, Kaan Tunceli and Insiya B. Poonawalla. Their work appears in journals such as Journal of Managed Care & Specialty Pharmacy, Diabetes, International Journal of COPD, Drugs & Aging and Molecular Cancer Therapeutics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.